NFE2L2 and cancer: Although further investigation is required to determine the precise involvement of this transcription factor in the metabolic reprogramming of CSCs, such as the redirection of glucose and glutamine towards the pentose phosphate pathway as observed in typical cancer cells, NRF2 seems to operate downstream primarily.